Efficacy was assessed by time to ART discontinuation or virologic failure , virologic failure/death and death ; safety by time to ART discontinuation because of a protocol-defined toxicity and first grade 3 adverse event ; immunology and growth by changes in CD4 % , weight/height World Health Organization z-scores from entry to week 48 .